Mycolactone Suppresses T Cell Responsiveness by Altering Both Early Signaling and Posttranslational Events
- 30 December 2009
- journal article
- research article
- Published by Oxford University Press (OUP) in The Journal of Immunology
- Vol. 184 (3) , 1436-1444
Abstract
Mycolactone is a diffusible lipid toxin produced by Mycobacterium ulcerans, the causative agent of a necrotizing skin disease referred to as Buruli ulcer. Intriguingly, patients with progressive lesions display a systemic suppression of Th1 responses that resolves on surgical excision of infected tissues. In this study, we examined the effects of mycolactone on the functional biology of T cells and identified two mechanisms by which mycolactone suppresses cell responsiveness to antigenic stimulation. At noncytotoxic concentrations, mycolactone blocked the activation-induced production of cytokines by a posttranscriptional, mammalian target of rapamycin, and cellular stress-independent mechanism. In addition, mycolactone triggered the lipid-raft association and activation of the Src-family kinase, Lck. Mycolactone-mediated hyperactivation of Lck resulted in the depletion of intracellular calcium stores and downregulation of the TCR, leading to impaired T cell responsiveness to stimulation. These biochemical alterations were not observed when T cells were exposed to other bacterial lipids, or to structurally related immunosuppressors. Mycolactone thus constitutes a novel type of T cell immunosuppressive agent, the potent activity of which may explain the defective cellular responses in Buruli ulcer patients.Keywords
Funding Information
- Agence Nationale de la Recherche (ANR-07-MIME-016-01)
- National Institute of Allergy and Infectious Diseases
- National Institutes of Health (N01-AI-25469)
This publication has 36 references indexed in Scilit:
- Immunosuppressive Signature of CutaneousMycobacterium ulceransInfection in the Peripheral Blood of Patients with Buruli Ulcer DiseaseThe Journal of Infectious Diseases, 2009
- Buruli ulcer disease: prospects for a vaccineMedical Microbiology and Immunology, 2009
- Dynamics of the Cytokine Response toMycobacterium ulceransduring Antibiotic Treatment forM. ulceransDisease (Buruli Ulcer) in HumansClinical and Vaccine Immunology, 2009
- Immunosuppression and treatment-associated inflammatory response in patients withMycobacterium ulceransinfection (Buruli ulcer)Expert Opinion on Biological Therapy, 2008
- Mycolactone Diffuses from Mycobacterium ulcerans–Infected Tissues and Targets Mononuclear Cells in Peripheral Blood and Lymphoid OrgansPLOS Neglected Tropical Diseases, 2008
- Mycolactones: immunosuppressive and cytotoxic polyketides produced by aquatic mycobacteriaNatural Product Reports, 2008
- Mycolactone-Mediated Inhibition of Tumor Necrosis Factor Production by Macrophages Infected withMycobacterium ulceransHas Implications for the Control of InfectionInfection and Immunity, 2007
- Selective suppression of dendritic cell functions by Mycobacterium ulcerans toxin mycolactoneJournal of Experimental Medicine, 2007
- Cytokine Responses to Stimulation of Whole Blood from Patients with Buruli Ulcer Disease in GhanaClinical and Vaccine Immunology, 2005
- An Integrated Stress Response Regulates Amino Acid Metabolism and Resistance to Oxidative StressMolecular Cell, 2003